| # | Drug | Count |
|---|---|---|
| 0 | FOLIC ACID | 12 |
| 1 | VALPROATE SODIUM | 10 |
| 2 | CLONAZEPAM | 7 |
| 3 | OXCARBAZEPINE | 7 |
| 4 | ADALIMUMAB | 6 |
| 5 | LAMOTIRIGINE | 6 |
| 6 | LAMOTRIGINE | 6 |
| 7 | LAMOTRIGINE CHEWABLE DISPERSIBLE | 6 |
| 8 | LAMOTRIGINE EXTENDED-RELEASE | 6 |
| 9 | PAROXETINE HYDROCHLORIDE | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SECNIDAZOLE | 5 | 0.0177 |
| 1 | ESTRADIOL VALERATE | 2 | 0.0026 |
| 2 | BARICITINIB | 2 | 0.0007 |
| 3 | TERBUTALINE SULFATE | 1 | 0.0005 |
| 4 | VALPROATE SODIUM | 10 | 0.0005 |
| 5 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 4 | 0.0005 |
| 6 | EFAVIRENZ | 5 | 0.0005 |
| 7 | OXCARBAZEPINE | 7 | 0.0004 |
| 8 | ELOSULFASE ALFA | 2 | 0.0004 |
| 9 | DOXEPIN HYDROCHLORIDE | 4 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Survival of Motor Neuron 2 Splicing Modifier [EPC] | 1 | 0.0002 |
| 1 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 5 | 0.0002 |
| 2 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 2 | 0.0001 |
| 3 | Vitamin K [EPC] | 1 | 0.0001 |
| 4 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 5 | 0.0001 |
| 5 | Quinolone Antimicrobial [EPC] | 1 | 0.0001 |
| 6 | Progesterone [EPC] | 2 | 0.0001 |
| 7 | Nitroimidazole Antimicrobial [EPC] | 5 | 0.0001 |
| 8 | Aminosalicylate [EPC] | 6 | 0.0001 |
| 9 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 6 | 0.0001 |